MK Proteins
Ticker > Company >

MK Proteins share price

MK Proteins Ltd.

  74.05 K   162   13 NSE: MKPL SECTOR: Edible Oil

3.98
+0.02 (0.51%)
BSE: 14 Oct 04:01 PM

Buy on Angel One

Price Summary

Today's High

₹ 4.03

Today's Low

₹ 3.93

52 Week High

₹ 7.05

52 Week Low

₹ 3.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 149.4 Cr.

Enterprise Value

₹ 185.15 Cr.

No. of Shares

37.54 Cr.

P/E

31.81

P/B

1.92

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  2.07

CASH

₹ 0.44 Cr.

DEBT

₹ 36.19 Cr.

Promoter Holding

74.82 %

EPS (TTM)

₹  0.13

Sales Growth

43.02%

ROE

9.37 %

ROCE

10.27%

Profit Growth

-18.68 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year43.02%
3 Year6.74%
5 Year4.24%

Profit Growth

1 Year-18.68%
3 Year-14.52%
5 Year-8.05%

ROE%

1 Year9.37%
3 Year14.15%
5 Year19.29%

ROCE %

1 Year10.27%
3 Year14.24%
5 Year17.06%

Debt/Equity

0.4743

Price to Cash Flow

27.49

Interest Cover Ratio

5.9587

CFO/PAT (5 Yr. Avg.)

0.120414704113304

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 74.82 0.00
Mar 2026 74.82 0.00
Dec 2025 74.82 0.00
Sep 2025 74.82 0.00
Jun 2025 74.82 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy liquidity position with current ratio of 2.2159.
  • The company has a high promoter holding of 74.82%.

 Limitations

  • The company has shown a poor profit growth of -14.5226431401599% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.73650313916561% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 114.95 32.43 89.56 145.94 115.16
Total Expenditure 109.44 31.39 87.19 143.44 112.65
Operating Profit 5.51 1.05 2.36 2.5 2.51
Other Income 0 0.12 0.02 0.12 0
Interest 0.7 0.06 0.3 0.79 0.52
Depreciation 0.1 0.11 0.12 0.11 0.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.71 1 1.97 1.72 1.85
Tax 1.19 0.25 0.54 0.58 0.47
Profit After Tax 3.51 0.75 1.43 1.14 1.38
Adjusted EPS (Rs) 0.09 0.02 0.04 0.03 0.04

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 255.89 314.86 245.41 267.71 382.88
Total Expenditure 240.39 297.83 228.76 255.22 371.42
Operating Profit 15.5 17.03 16.65 12.49 11.46
Other Income 0.34 0.67 0.45 0.48 0.26
Interest 0.89 1.9 1.1 1.16 1.89
Depreciation 0.91 0.82 0.53 0.35 0.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.04 14.99 15.47 11.45 9.39
Tax 3.86 4.06 4.26 3.05 2.56
Net Profit 10.18 10.93 11.21 8.4 6.83
Adjusted EPS (Rs.) 0.27 0.29 0.3 0.22 0.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 4.17 12.51 37.54 37.54 37.54
Total Reserves 35.43 37.35 23.54 31.93 38.76
Borrowings 2.65 2.54 0 0.83 1.05
Other N/C liabilities -0.22 0.73 0.83 0.93 1.02
Current liabilities 43.81 52.06 35.92 60.98 54.02
Total Liabilities 85.85 105.2 97.83 132.2 132.38
Assets
Net Block 3.11 3.3 2.77 3.68 4.73
Capital WIP 0 0 5.9 6.66 7.1
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.42 0.89 1.36 1.33 0.81
Other N/C Assets 0 0 0.01 0.04 0.04
Current Assets 82.31 101.02 87.79 120.49 119.71
Total Assets 85.85 105.2 97.83 132.2 132.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 14.04 14.99 15.47 11.45 9.39
Adjustment 1.51 2.2 1.25 1.06 2.13
Changes in Assets & Liabilities -20.89 -18.23 19.21 -24.44 -3.53
Tax Paid -3.94 -4.83 -3.51 -4.2 -2.56
Operating Cash Flow -10.12 -5.87 32.42 -16.13 5.43
Investing Cash Flow -1.53 0.01 -5.88 -1.48 -1.6
Financing Cash Flow 11.66 5.92 -26.51 17.55 -3.43
Net Cash Flow 0.01 0.06 0.03 -0.06 0.4

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Last Updated on:
Brief about MK Proteins
X